"Complicant calcium D3"

"Complymium Calcium D3" is available in the form of tablets of a round biconvex form. Their surface is roughened and porous, white or with a creamy shade with gray impregnations. Tablets "Complivit Calcium D3" have a slight fruity odor.

As auxiliary substances, the preparation includes lactose, potato starch, low molecular weight polyvinylpyrrolidone (povidone), citric acid, vivasol (croscarmellose sodium), magnesium stearate, aspartame, powder flavor (orange).

The active substance is calcium carbonate and colcalciferol.

"Complivit Calcium D3" refers to drugs that regulate the exchange of phosphorus and calcium. This combination drug has an effect aimed at reducing resorption and increasing bone density . In addition, the drug is able to compensate for the lack of colocalciferol and calcium in the body, increase their absorption in the intestines and re-absorption of phosphate (reabsorption) in the kidneys. The drug greatly contributes to bone mineralization.

By the participation of calcium, the formation of bone tissue, it also contributes to the stable maintenance of the heart. In addition, he is involved in the transmission of nerve impulses.

Absorption of calcium in the intestines is carried out at the expense of colocalciferol. This substance is also involved in the mineralization and formation of the tissue of the teeth and bones.

At the expense of active substances, the production of parathyroid hormone stimulating bone resorption is reduced.

The drug is prescribed for prevention and as a complex therapy of osteoporosis (menopause, steroid, senile, idiopathic) and deficiency of D3-vitamin and calcium.

It is recommended to take the drug during meals, chewing or swallowing the tablet as a whole.

As a rule, the medicine is tolerated well, however, as side effects, constipation, nausea, diarrhea, stomach pain, flatulence are possible. Perhaps the appearance of hypercalciuria or hypercalcemia. The presence of these complications is a contraindication to the use. The drug is also not prescribed for calcium nephrolithiasis, hypervitaminosis D, decalcifying tumors (myeloma, sarcoidosis, bone metastases), osteoporosis due to immobilization, phenylketonuria, pulmonary tuberculosis in active form, chronic renal failure, children under 3 years of age and with hypersensitivity to Contained in the preparation components.

During the prenatal period and during breastfeeding, the drug should be taken under the supervision of a doctor. An increased dose (overdose) can lead to disturbances in the child's psychophysical development.

The synonym for the drug is "Complivit Calcium D3 Forte." This medication is also available in the form of chewable tablets with mint flavor.

For young children "Complivit Calcium D3" is released in the form of a powder from which a suspension for oral administration is prepared. The prepared suspension has a white or almost white color with a characteristic orange odor.

In order to avoid overdose, "Complymitis Calcium D3" for infants is not recommended to be used simultaneously with complexes containing D3-vitamin and calcium. Care should be taken to use the drug for newborns, since the sensitivity of children to the components may be different, and even minor doses can lead to hypervitaminosis.

Taking the drug in prescribed doses does not cause side effects. If you need to combine it with other medicines, you should consult a doctor. Only a specialist is able to figure out whether this harms the body.